Skip to content
Recall Observatory FDA recall evidence

Drug product

Atorvastatin Calcium Tablets, 20 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-828-90

D-071-2013

November 09, 2012

Class II

Product summary

Firm
Ranbaxy Inc.
Event
Event 63759
Status
Terminated
Classification
Class II
Quantity
203,198 Bottles
Official record key
drug-enforcement:D-071-2013

Official wording

Reason: Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.

Code information: Lot #s: 2436731, 2437381, 2437940, 2437942, 2437945, 2437947, 2437952, 2437953, 2437960, 2440676, 2440677, 2440680, 2440681, Exp 08/31/2014.

Distribution pattern: Nationwide and PR

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter